article thumbnail

New Research Shows Promising Treatment Results for Migraine Sufferers

Veriheal

Fortunately for migraine sufferers, the real-time benefits of cannabis on migraines has been researched and recorded in a study published in July 2020. . The objective of the study was to examine the effectiveness of the cannabis plant (the whole dried plant) as a treatment for headache- and migraine-related pain.

article thumbnail

Could Marijuana Be a Treatment for Malaria?

Leafwell

The World Health Organization (WHO) estimates that there were 229 million cases of malaria in 2019, resulting in 409,000 deaths. Even today, malaria infects millions and kills hundreds of thousands every year.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

GW Pharmaceuticals receives approval for EPIDYOLEX® (cannabidiol) from the MHRA for the treatment of seizures associated with tuberous sclerosis complex

Cannabis Law Report

GW was initially granted marketing authorisation for this medicine in the UK in September 2019 as an adjunctive therapy for seizures associated with Lennox Gastaut syndrome (LGS) or Dravet syndrome, in conjunction with clobazam, for patients two years of age and older. Food and Drug Administration (FDA) for use in the U.S. In the U.S.,

article thumbnail

Could Marijuana Be a Treatment for Malaria?

Leafwell

The World Health Organization (WHO) estimates that there were 229 million cases of malaria in 2019, resulting in 409,000 deaths. Even today, malaria infects millions and kills hundreds of thousands every year.

article thumbnail

New Jersey approves medical marijuana as treatment for opioid addiction

SpeedWeed

Prescription painkiller addicts can now seek medical cannabis as a form of treatment in New Jersey. The state will also eliminate a prior authorization requirement for Medicaid recipients to receive medication-assisted treatment (MAT). — Governor Phil Murphy (@GovMurphy) January 23, 2019. “To be determined.”

article thumbnail

BetterLife Files Patent for TD-0148A for Treatment of Cluster Headaches and Related Disorders

Cannabis Law Report

We are excited to be developing and bringing to market treatments addressing cluster headaches, neuropathic pain and range of mental health conditions, including depression, anxiety and PTSD, and related disorders.”. billion in 2019 and projected to reach near US$25 billion by 2030. billion in 2019) at a CAGR of 2.25%.

article thumbnail

Doctors Get New Clinical Guidelines for Managing Chronic Pain With Cannabis, Courtesy of Canadian Researchers

Veriheal

Nonetheless, guidelines pertaining to the use of cannabis-based treatments for chronic pain relief have been somewhat hazy…up until now. New guidelines for cannabis in chronic pain were recently published by a group of Canadian researchers. The team peered into the findings of numerous articles published between 2001 and 2019.